Development
NeueHealth, Inc.
NEUE
$6.77
$0.000.00%
NYSE
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -100.07% | -- | 10.36% | 16.57% | -5.38% |
| Total Depreciation and Amortization | -53.92% | -- | -23.31% | 9.46% | -37.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 153.75% | -- | -62.93% | 125.02% | 1,337.92% |
| Change in Net Operating Assets | -205.57% | -- | -185.54% | 12.12% | -1,414.05% |
| Cash from Operations | -171.81% | -- | -226.87% | 181.24% | -132.88% |
| Capital Expenditure | 96.39% | -- | 66.07% | 39.69% | 36.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.76% | -- | 209.56% | -64.29% | 1,024.05% |
| Cash from Investing | 102.34% | -- | 208.48% | -66.65% | 271.44% |
| Total Debt Issued | -83.55% | -- | -- | -200.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -99.61% | -99.88% | -33.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,831.16% | -- | -- | -- | 93.60% |
| Cash from Financing | -84.91% | -- | -100.30% | 9.53% | 25,662.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -457.86% | -- | -84.26% | 211.27% | 132.36% |